Vimarsana
Biggest News Aggregation in the World

5 Asa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 5 Asa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 5 Asa Today - Breaking & Trending Today

Young Patients with UC Likely to Discontinue Treatment, Study Finds - Vimarsana News

Young Patients with UC Likely to Discontinue Treatment, Study Finds

Published: September 20, 2023

The greatest level of treatment discontinuation was seen among patients aged 18-24 years, highlighting an increased risk of early disease relapse.

Source: hcplive.com
Related Topics:
United KingdomCity OfSonia SaxenaNishani JayasooriyaImperial Child Health UnitSt George University LondonUnited Kingdom Clinical Practice Research DatalinkCrohn Colitis FoundationImperial College London Sonia SaxenaImperial College LondonPublic HealthImperial CollegeUniversity LondonPublished SeptemberAccessed SeptemberUlcerative Colitis5 Asa5 Aminosalicylic AcidInflammatory Bowel Disease
Study Details Trends in Retransition, Discontinuation of Infliximab Biosimilars - Vimarsana News

Study Details Trends in Retransition, Discontinuation of Infliximab Biosimilars

Published: September 20, 2023

More patients who retransitioned to originator infliximab after switching to a biosimilar discontinued infliximab than patients who remained on the biosimilar.

Source: hcplive.com
Related Topics:
Thijs GiezenSpaarne GasthuisBiosimilars Nederland Thijs GiezenFoundation Pharmacy For HospitalsUs Food Drug AdministrationCenters For DiseaseUs Centers For DiseaseBiosimilars NederlandDisease ControlFoundation PharmacyMedisch Spectrum TwenteAccessed SeptemberInflammatory Bowel Disease5 Aminosalicyclic Acids5 Asa